In ESCC patients, the AUC value for five-year survival of the prediction model, including pathological M stage, N stage, T stage, and RAD21 expression, was significantly improved from 0.554 to 0.737 (Figure 4D). The gene discussed is RAD21; the disease is esophageal squamous cell carcinoma.